Summary. Monoclonal antibodies (MAbs) to the core antigen region of lipopolysaccharide (LPS) of Pseudomonas aeruginosa were produced from mice immunised with whole cells of heat-killed rough mutants of Pseudomonas aeruginosa expressing partial or complete core LPS. MAbs were screened in an enzyme-linked immunosorbent assay (ELISA) against three different antigen cocktails : S-form LPS from three P . aeruginosa strains, R-form LPS from six P . aeruginosa strains and, as a negative control, R-form LPS from Salmonefla typhimurium and Escherichia coli. Selected MAbs were subsequently screened against a range of extracted LPS and whole cells from both reference strains and clinical isolates of P . aeruginosa. The antibodies were also screened in ELISA against whole-cell antigens from other Pseudomonas spp. as well as strains of Haemophilus influenzae, Neisseria subjlava and Staphylococcus aureus. Five MAbs reacting with the core component of P. aeruginosa LPS were finally selected. Two of these, MAbs 360.7 and 304.1.4, were particularly reactive in immunoblots against unsubstituted core LPS, including that from 0-antigenic serotypes of P. aeruginosa. The MAbs also reacted with some of the other Pseudomonas spp., but not with P. cepacia or Xanthomonas (Pseudomonas) maltophilia. Cross-reactivity with whole cells from other bacterial species was minimal or not observed. Reactivity of MAbs with some Staph. aureus strains was observed, and binding to the protein A component was implicated. The reactivity of the M Abs was investigated further by flow cytometry and immunogold electronmicroscopy. The suitability of the MAbs for an immunological assay for detection of P. aeruginosa in respiratory secretions from C F patients is discussed.
Introduction
fseudornonas aeruginosa is an opportunist pathogen par excellence, responsible for a diverse range of infections in patients compromised by chemotherapy, injury, surgical procedures or underlying disease, and by the inherited disease cystic fibrosis (CF). Pulmonary colonisation of patients with CF by P. aeruginosa can be diagnosed by bacteriological culture and detection of pseudomonas-specific antibodies. 1-3 However, in the early stages of asymptomatic colonisation such techniques may be unhelpful.
There has been increasing interest in the development of immunoassays which can detect infective agents directly in clinical specimens and be adapted to the. rapid screening of a large number of The development of an immunoassay based on a monoclonal antibody (MAb) for the early detection of P. ueruginosa antigens in saliva and sputum specimens from CF patients was considered a potentially useful diagnostic technique. P. aeruginosa is serologically heterogeneous and contains at least 20 different heat-stable 0-antigens.?
The aim of the current study was to produce and characterise MAbs specific for P. aeruginosa and then assess their suitability for the detection of any of the distinct serotypes which may colonise individual CF patients. P. aeruginosa produces several intra-and extra-cellular antigens. Amongst these, lipopolysaccharide (LPS) is highly immunogenic and readily released from bacterial cell^.*^^ Therefore, the common core region of LPS was considered to be an appropriate antigen for the production of anti-P. aeruginosa MAbs for use in an immunoassay to detect P. aeruginosa in clinical specimens from CF patients. Immunisation procedure and production of MAbs P. aeruginosa was grown in nutrient broth containing yeast extract 0.5 % w/v (NYB), washed twice with phosphate-buffered saline (PBS, pH 7.2) and resuspended to a density of 10' cells/ml. Five female BALB/c mice were immunised by intravenous (i.v.) injection with lo7 heat-killed (100 "C for 5 min) cells. Each mouse received 0 1 ml of cells from P . aeruginosa PAC608 (full core mutant) on days 1,2,3,8,9 and 10 followed by cells from P . aeruginosa PAC605 (partial core mutant) on days 22,23 and 24. Blood was taken from the tail vein of each mouse on days 1 (preinoculation), 20,31 and 38, and the antibody response was measured by ELISA (see below). A mouse with serum showing a strong, cross-reactive antibody response to P. aeruginosa LPS antigens was selected for fusion. The mouse was given a booster injection of 0.1 ml of heat-killed cells of PAC608 (10' cells), i.v., and was killed 3 days later. Mouse spleen cells were fused with cells of the NS-1 plasmacytoma cell line'' by the method of Oi and Her~enberg.'~ Hybridomas producing anti-P . aeruginosa LPS antibodies were screened by ELISA (see below). Antibody-positive hybrids were cloned by limiting dilution.
Materials and methods

Bacterial strains P . ueruginosa R-mutants defective in the production
Preparation of LPS
Extraction of LPS from bacterial strains expressing the S-form LPS phenotype was based on the aqueous phenol method of Westphal and Luderitz." The aqueous phenol, chloroform, petroleum ether method of Galanos et al., 15 incorporating the diethyl ether precipitation of LPS described by Qureshi et a1. 16 (as described by Hancock and Poxton17), was used to prepare LPS from bacteria expressing the R-form LPS .
Characterisation of MAbs
Isotype determination. The class and subclass of MAbs in culture supernates were determined by a mouse MAb isotyping kit (RPN29: Amersham International plc). An ELISA was used (a) to detect the antibody response of mice to vaccination; (b) to screen hybridomas for the production of anti-P. aeruginosa antibody; and (c) to test the reactivity of MAbs against other bacterial strains. A primary ELISA screen consisting of three different LPS cocktails was used for an initial assessment of the reactivity of antibodies in sera from mouse-tail samples and in hybridoma supernates. Extracted LPS antigens were complexed with polymyxin as described by Scott and Barclay'' and antigen cocktails were formed by the addition of equimolar proportions of individual complexes. Cocktail-A consisted of 0-antigenic s-form LPS from three serotype strains of P. aeruginosa (01, 0 2 and 0 1 1); cocktail-B consisted of core R-LPS from six LPS R-mutants (PAC556, PAC557, PAC605, PAC608, PAC609 and PAC6 1 1) ; cocktail-C (negative control) consisted of LPS from S. typhirnurium 1542 and E. coli R1. Hybridomas producing a strong antibody response directed to one or both of the P. aeruginosa LPS cocktails were selected and the antibodies were subsequently tested in a secondary ELISA consisting of the individual LPS antigens contained in the LPS cocktails of the primary screen. Hybridomas producing antibodies of interest were further screened in ELISA against a comprehensive range of antigens which included additional LPS-polymyxin complexes, individual pseudomonas vaccine antigens PVA-1-16 which comprise the polyvalent pseudomonas extract vaccine (PEV),19 and whole-cell bacterial antigens. All antigens for ELISA studies were diluted in carbonatebicarbonate coating buffer (pH 9.6) and added to the wells of polystyrene microplate 8-well strips (Nunc, ' polysorb ') at I00 pullwell. LPS-polymyxin complexes were diluted 1 in 50 in coating buffer and vaccine antigens were coated at 1 pg/ml. Bacterial whole cells (grown overnight in NYB and washed twice with PBS) were resuspended to a density of lo7 cells/ml in coating buffer and added to the microtitration plate wells, and the plates were centrifuged at 1400g for 5min to sediment bacteria to the wells. After washing with wash buffer (PBS containing Tween 20 0-05 % v/v and sodium azide 002 % w/v), all plates were post-coated with post-coat buffer (PBS containing bovine serum albumin, BSA, 5 (YO w/v) at 100 pl/well. After being washed four times with wash buffer, plates were stored at -20 "C until use.
Primary antibody (sera from mouse tail samples diluted 1 in 100, or supernate from hybridomas diluted 1 in 5) was added (100 pl) to each well. Antibody diluent was PBS with Tween 20 0.05% v/v, BSA, Enzyme-linked immunosorbent assay (ELISA) . 0.5 '!o w/v, polyethylene glycol 6000 4 % w/v and sodium azide 0.02% w/v. After incubation at 37 "C for 90 min, plates were washed four times with wash buffer. Urease-conjugated anti-mouse Ig (Sera Lab) was diluted 1 in 500 in diluent, and then 1OOpl was added to each well. The plates were incubated for a further 90 min at 37 "C. Thereafter they were washed and rinsed, and I00 pl of urease substrate (Sera Lab) was added to each well. Finally. the plates were incubated for 60min at room temperature and the optical density (OD) of wells was read at 590 nm in a Titertek Multiscan. Results were expressed after subtraction of the corresponding OD of negative control wells (coated only with BSA) for each antibody sample. LPS was prepared by the proteinase K method of Hitchcock and Brown2' and separated on polyacrylamide 14 YO gels with the buffer system of Laemmli2' but without sodium dodecyl sulphate in the stacking and separating gel buffers.
Inzmunoblotting.
Separated antigens were transferred to nitrocellulose membranes (Schleicher and Schuell, pore size 0.2 pm) by the method of Towbin et a1. 22 and processed by the method of Hancock and Poxton." Antigens were probed with hybridoma culture supernate diluted 1 in 5 for 3 h at room temperature and the immune complexes were detected with anti-mouse Ig horseradish peroxidase conjugate (ICN Biomedicals) and HRP colour reagent (BioRad).
The binding of MAbs (hybridoma supernates) to whole bacteria was analysed by the flow cytometry method described by Nelson et al. 23 Immunogold electronmicroscopy. P . aeruginosa strains were grown overnight in NYB, and harvested by centrifugation at 10000 g for 10 min. Cells for thin sections and the subsequent immunoassay were prepared as described by Hancock and Poxton." MAb supernates and the anti-mouse IgG immunogold conjugate (10 nm particle size, Sigma) were diluted 1 in 10 in antibody diluent which was the same as for the ELISA studies. Sections were examined before and after staining with aqueous uranyl acetate, in a Hitachi 12A electronmicroscope at 75 kV.
The ELISA for detection of protein A was performed as described by Warnes et al.24
Protein A assay.
Results
A total of 530 hybridoma supernates were screened in ELISA; 42 hybridomas produced an ELISA OD of > 0.5 in the initial screening against the P . aeruginosa R-and S-LPS cocktails. Antibody-positive hybrids were cloned and five hybridomas that produced specific antibody were characterised further.
Is0 type determination
One MAb (73.5) was classified as IgG,, two MAbs (304.1.4 and 360.7) as IgG,, and two MAbs as IgG, (61.32 and 334.4).
Reaction in ELISA
The five MAbs selected for study produced a positive response against all the P . aeruginosa wholecell antigens used in the screening ( fig. 1) . A strong reaction (ELISA OD > 1.0) against most of the P . aeruginosa whole-cell antigens was particularly marked for MAbs 304. Confirmation of the cross-reactive nature of the five MAbs with all serotypes of P. aeruginosa were also provided by the positive response of each MAb to the cell-wall vaccine antigens (PVA), serotypes 01-01 6 ( fig. 2) . The strongest reactions were again observed with MAbs 304.1.4 and 360.7. The MAbs also reacted with each of the extracted P . aeruginosa LPS antigens. In ELISA, the response of the five MAbs to core R-LPS from the PAC mutants tended to be lower towards the shortest core structure PAC605 and the complete core structures PAC557 and PAC608. The antibodies did not react with the enterobacterial R-LPS antigens from E. coli Rl and S. typhimurium 1542.
Immuno blot t ing
The immunoblot of MAb 360.7 is shown in fig. 3 . 
Flow cytometry on whole bacteria
The binding of MAbs 304.1.4, 360.7 and 334.4 to whole P. aeruginosa cells was analysed by flow cytometry. The highest percentage values of bacteria exhibiting positive fluorescence were observed for the LPS R-mutants that expressed core or partial core structures. The MAbs also reacted with P. aeruginosa whole cells expressing O-antigen LPS. No reactivity was observed with whole cells of P. cepacia or the enterobacterial R-mutants E. coli R1 and S. typhimurium 1542 (table 11) .
Immunogold electronmicroscopy was also used to assess the binding of MAbs to P . aeruginosa cells processed for thin-sections. Fig. 4a and b shows the binding of MAb 360.7 to P . aeruginosa PAC611, which expresses only a partial core LPS, and to P. aeruginosa serotype 0 1 . There was negligible binding of the MAbs to cells of P . cepacia (data not shown).
Discussion
The aim of this investigation was to prepare MAbs suitable for an immunoassay for the detection of nonmucoid strains of P. aeruginosa. MAbs recognising P . aeruginosa core LPS unsubstituted by O-serotype antigens were isolated and characterised. The MAbs were shown to be cross-reactive with core LPS antigens belonging to a variety of reference and clinical P. aeruginosa strains. The pan-reactive core-specific response of the MAbs, particularly MAbs 304.1.4 and 360.7, supports the idea of the presence of a common antigenic structure in the core region of P. aeruginosa
LPS.
The inner core region of P . aeruginosa LPS is believed to be homogeneous and also common to most gram-negative bacteria, whereas the outer core region is considered to be heterogene~us~~' 26 and different from that of other gram-negative genera.27 Failure of the MAbs to react with LPS from E. coli R1 or S. typhimurium 1542, both of which express an Ra core LPS chemotype (complete core), or with whole cells of enterobacteria demonstrate that the MAbs generated recognise core epitopes in P. aeruginosa LPS which are not present in these selected strains of Enterobacteriaceae.
Failure of the MAbs to react with the ladder pattern of core LPS substituted with 0-antigen, as shown by the immunoblot analysis, suggested that the epitope recognised was present at the distal end of the unsubstituted core oligosaccharide which became unavailable when 0-polysaccharide was linked. The fact that the MAbs showed strong reactions in ELISA and flow cytometry with P. aeruginosa whole cells expressing S-LPS antigen indicated that there was sufficient unsubstituted core glycolipid to allow binding by the MAbs. This may be a reflection of the low capping frequency of P. aeruginosa LPS (the percentage of core LPS constituents covered with 0-antigen) leaving a large percentage of core determinants exposed at the cell surface.25*27~28 In contrast, however, this low level of covering with 0-polymer The MAbs investigated in this study were shown to react with various forms of P. aeruginosa LPS, including extracted LPS preparations, cell-wall extracts and whole bacterial cells, including those immobilised on microtitration-plate wells and those prepared for flow cytometry.
Cross-reactivity of the MAbs with whole cells representing a number of other Pseudomonas spp. indicates that these species contain core LPS similar in composition and structure to P. aeruginosa. Alternatively, their LPS may be structurally dissimilar, but serologically cross-reactive with that of P . aeruginosa. The absence of a significant response to (formerly Pseudomonas) X . maltophilia confirms the observations of Neal and Wilkinson3' who reported similarities between the LPS of P. maltophilia and that of some Xunthomonas spp. The lack of a significant response to P. cepacia may also reflect some of the reported differences in the structure of P. cepacia LPs. 31 MAbs against P . aeruginosa core LPS and reactive with some26 or all serotypes have been reported p r e v i~u s l y .~~ The MAbs described in this study are LPS-specific, pan-reactive with all P . aeruginosa regardless of serotype and, therefore, potentially useful for the detection of any of the serotype strains which may colonise individual CF patients. Recent studies have focused on the incorporation of the MAbs into a rapid immunological assay for the early diagnosis of asymptomatic colonisation of the CF respiratory tract. 
